Cite
HARVARD Citation
Girda, E. et al. (2022). Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer. International journal of gynecological cancer. 32 (8), pp. 1032-1038. [Online].